The SYNERGY MEGATRON is a platinum-chromium (PtCr) drug-eluting coronary stent (DES) with an abluminal, bioabsorbable polymer carrying everolimus (~1 μg/mm²). Its low initial polymer load and abluminal coating are designed to support faster healing, reduce thrombosis risk, and potentially shorten the duration of DAPT in appropriate patients.
The SYNERGY XD Coronary Stent System - Eluting Coronary Stent System is a next-generation platinum-chromium drug-eluting stent (DES) with an ultra-thin bioabsorbable polymer coating applied only to the abluminal (outer) surface, designed to improve healing and reduce the need for extended dual antiplatelet therapy.
The SYNERGY MEGATRON Everolimus-Eluting Platinum Chromium Coronary Stent System is designed for large coronary vessels, combining strong radial support with advanced drug delivery technology. Its bioresorbable polymer and abluminal coating help reduce thrombosis risk and minimize the need for long-term dual antiplatelet therapy.
The SYNERGY XD Coronary Stent System, made from a platinum-chromium alloy and coated with everolimus in a bioresorbable polymer, is designed to reduce the risk of stent thrombosis and minimize the need for long-term dual antiplatelet therapy.